ENTA

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Enanta Pharmaceuticals Inc

NASDAQ | ENTA

14.14

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$402.21M

Market Cap

-

P/E Ratio

-3.92

EPS

$15.34

52 Week High

$4.09

52 Week Low

HEALTHCARE

Sector

ENTA Chart

Recent Chart
Price Action

ENTA Technicals

Tags:

ENTA Earnings

Yearly Income Statement (As of Sep 30, 2025)

Field Value (USD)
Gross Profit $65M
Total Revenue $65M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$85M
Selling General And Administrative $44M
Research And Development $107M
Operating Expenses $151M
Investment Income Net -
Net Interest Income $1.8M
Interest Income $9.4M
Interest Expense $7.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.1M
Income Before Tax -$84M
Income Tax Expense -$1.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$82M
Comprehensive Income Net Of Tax -
Ebit -$76M
Ebitda -$71M
Net Income -$82M

Revenue & Profitability

Earnings Performance

ENTA Financials

yearly Balance Sheet (As of Sep 30, 2025)

Field Value (USD)
Total Assets $281M
Total Current Assets $204M
Cash And Cash Equivalents At Carrying Value $32M
Cash And Short Term Investments $32M
Inventory -
Current Net Receivables $6.9M
Total Non Current Assets $76M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $157M
Other Current Assets $8.6M
Other Non Current Assets -
Total Liabilities $216M
Total Current Liabilities $49M
Current Accounts Payable $1.9M
Deferred Revenue -
Current Debt -
Short Term Debt $34M
Total Non Current Liabilities $167M
Capital Lease Obligations $58M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $201M
Other Current Liabilities $13M
Other Non Current Liabilities $111M
Total Shareholder Equity $65M
Treasury Stock -
Retained Earnings -$405M
Common Stock $214K
Common Stock Shares Outstanding $21M

yearly Cash Flow (As of Sep 30, 2025)

Field Value (USD)
Operating Cashflow -$19M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.1M
Capital Expenditures $13M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $40M
Cashflow From Financing -$27M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$82M

yearly Income Statement (As of Sep 30, 2025)

Field Value (USD)
Gross Profit $65M
Total Revenue $65M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$85M
Selling General And Administrative $44M
Research And Development $107M
Operating Expenses $151M
Investment Income Net -
Net Interest Income $1.8M
Interest Income $9.4M
Interest Expense $7.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.1M
Income Before Tax -$84M
Income Tax Expense -$1.7M
Interest And Debt Expense -
Net Income From Continuing Operations -$82M
Comprehensive Income Net Of Tax -
Ebit -$76M
Ebitda -$71M
Net Income -$82M

ENTA News

ENTA Profile

Enanta Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Enanta Pharmaceuticals Inc. is a targeted biotechnology firm based in Watertown, Massachusetts, specializing in the discovery and development of innovative small molecule therapeutics for viral infections and liver diseases. The company has developed a promising pipeline featuring candidates aimed at hepatitis B and a range of viral pathogens, demonstrating its strong scientific foundation and commitment to addressing critical healthcare needs. With a strategic focus on advancing proprietary programs, Enanta is poised to significantly influence the management of infectious diseases and liver health, offering improved treatment options and patient outcomes in these crucial areas.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
BITF
+12.58%
$3.49
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
INTC
+2.73%
$36.81
ADAP
-15.14%
$0.05
HOOD
+10.92%
$128.20
RUBI
-25.80%
$0.16
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CLSK
+13.01%
$15.20
ADD
-25.47%
$0.05
ASST
+2.65%
$1.16
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
BAC
+0.97%
$52.99
INHD
+2.21%
$0.23
ONMD
+31.69%
$1.87
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
CHR
-1.86%
$0.04
SNAP
+0.14%
$7.62
TSLA
+0.55%
$428.96
BMNU
+9.61%
$8.24
PCG
+1.78%
$16.01
CIFR
+10.05%
$21.07
PLUG
+2.09%
$2.02
ADTX
+19.42%
$3.75
AFMD
-34.94%
$0.18
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
F
+0.65%
$13.27
DEFT
+11.51%
$1.55
WULF
+7.27%
$15.92
NIO
+0.36%
$5.48
KWM
+12.77%
$0.74
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
GOOGL
-0.60%
$318.02
BTG
+3.13%
$4.61
SOFI
+3.18%
$29.39
VALE
+0.31%
$12.54
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
DVLT
-6.33%
$1.99
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
IBRX
+11.50%
$2.37
AG
+12.76%
$15.23
CAN
+12.59%
$1.03
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NGD
+5.86%
$8.30
LEN
+0.15%
$131.28
SHOT
-74.37%
$0.39
CRCA
+22.28%
$4.50
ZAPP
-46.30%
$0.15
HBI
-0.75%
$6.54
APLD
+7.21%
$26.74
PFE
+0.19%
$25.75
NVO
+1.38%
$49.38
GRAB
+2.67%
$5.46
GOOG
-0.73%
$317.92
AMD
+0.97%
$216.32
CRCG
+21.27%
$2.85
KO
+0.37%
$72.88
TMC
+14.32%
$6.66
C
+1.31%
$102.50
SNDK
+4.28%
$224.25
AGNC
-0.66%
$10.49
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
PLTR
+0.75%
$167.01
COMP
-0.76%
$10.42
NVTS
+6.83%
$8.91
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
BITF
+12.58%
$3.49
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
INTC
+2.73%
$36.81
ADAP
-15.14%
$0.05
HOOD
+10.92%
$128.20
RUBI
-25.80%
$0.16
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CLSK
+13.01%
$15.20
ADD
-25.47%
$0.05
ASST
+2.65%
$1.16
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
BAC
+0.97%
$52.99
INHD
+2.21%
$0.23
ONMD
+31.69%
$1.87
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
CHR
-1.86%
$0.04
SNAP
+0.14%
$7.62
TSLA
+0.55%
$428.96
BMNU
+9.61%
$8.24
PCG
+1.78%
$16.01
CIFR
+10.05%
$21.07
PLUG
+2.09%
$2.02
ADTX
+19.42%
$3.75
AFMD
-34.94%
$0.18
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
F
+0.65%
$13.27
DEFT
+11.51%
$1.55
WULF
+7.27%
$15.92
NIO
+0.36%
$5.48
KWM
+12.77%
$0.74
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
GOOGL
-0.60%
$318.02
BTG
+3.13%
$4.61
SOFI
+3.18%
$29.39
VALE
+0.31%
$12.54
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
DVLT
-6.33%
$1.99
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
IBRX
+11.50%
$2.37
AG
+12.76%
$15.23
CAN
+12.59%
$1.03
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NGD
+5.86%
$8.30
LEN
+0.15%
$131.28
SHOT
-74.37%
$0.39
CRCA
+22.28%
$4.50
ZAPP
-46.30%
$0.15
HBI
-0.75%
$6.54
APLD
+7.21%
$26.74
PFE
+0.19%
$25.75
NVO
+1.38%
$49.38
GRAB
+2.67%
$5.46
GOOG
-0.73%
$317.92
AMD
+0.97%
$216.32
CRCG
+21.27%
$2.85
KO
+0.37%
$72.88
TMC
+14.32%
$6.66
C
+1.31%
$102.50
SNDK
+4.28%
$224.25
AGNC
-0.66%
$10.49
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
PLTR
+0.75%
$167.01
COMP
-0.76%
$10.42
NVTS
+6.83%
$8.91
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.